Microbiotica Series C: €42M

Oct 16, 2026Public sources — Collected from public sources, not yet cross-checked.

Microbiotica raised €42 million (about $47.07 million) in a series c round led by British Business Bank, announced Oct. 16.

Facts

Company: Microbiotica
Amount: €42 million (about $47.07 million)
Currency: EUR
Stage: Series C
Announced: Oct 16, 2026
Instrument: Equity
FX rate: 1 EUR = 1.1208 USD on Oct 15, 2026

Investors

Led by: British Business Bank
Participants: Tencent IP Group Cambridge Innovation Capital Flerie Invest Seventure Partners

Use of funds

Advancement of MB310 into Phase 2 clinical development for ulcerative colitis.

As stated by the company.

Sources

1.New treatment for inflammatory bowel disease lands Microbiotica €42 million — EU-Startups, Oct 16, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 16, 2026